WallStSmart

Akso Health Group ADR (AHG)vsCosmos Health Inc. (COSM)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Cosmos Health Inc. generates 433% more annual revenue ($73.73M vs $13.83M). COSM leads profitability with a -33.1% profit margin vs -135.0%. COSM earns a higher WallStSmart Score of 36/100 (F).

AHG

Avoid

15

out of 100

Grade: F

Growth: 3.3Profit: 2.0Value: 5.3Quality: 9.0
Piotroski: 5/9Altman Z: 12.00

COSM

Hold

36

out of 100

Grade: F

Growth: 6.0Profit: 2.0Value: 5.0Quality: 4.5
Piotroski: 4/9Altman Z: -2.45
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AHGUndervalued (+10.2%)

Margin of Safety

+10.2%

Fair Value

$1.57

Current Price

$0.75

$0.82 discount

UndervaluedFair: $1.57Overvalued

Intrinsic value data unavailable for COSM.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AHG2 strengths · Avg: 10.0/10
Debt/EquityHealth
0.0010/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
12.0010/10

Safe zone — low bankruptcy risk

COSM2 strengths · Avg: 9.0/10
Price/BookValuation
1.4x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
28.8%8/10

Revenue surging 28.8% year-over-year

Areas to Watch

AHG4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$634.05M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-89.4%2/10

ROE of -89.4% — below average capital efficiency

Revenue GrowthGrowth
-12.9%2/10

Revenue declined 12.9%

COSM4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$40.92M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-106.6%2/10

ROE of -106.6% — below average capital efficiency

Free Cash FlowQuality
$-1.78M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : AHG

The strongest argument for AHG centers on Debt/Equity, Altman Z-Score.

Bull Case : COSM

The strongest argument for COSM centers on Price/Book, Revenue Growth. Revenue growth of 28.8% demonstrates continued momentum.

Bear Case : AHG

The primary concerns for AHG are EPS Growth, Market Cap, Return on Equity.

Bear Case : COSM

The primary concerns for COSM are EPS Growth, Market Cap, Return on Equity.

Key Dynamics to Monitor

AHG profiles as a turnaround stock while COSM is a growth play — different risk/reward profiles.

COSM carries more volatility with a beta of 4.17 — expect wider price swings.

COSM is growing revenue faster at 28.8% — sustainability is the question.

COSM generates stronger free cash flow (-2M), providing more financial flexibility.

Bottom Line

COSM scores higher overall (36/100 vs 15/100) and 28.8% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Akso Health Group ADR

HEALTHCARE · MEDICAL DISTRIBUTION · China

Akso Health Group ADR is a leading entity in the healthcare sector, dedicated to providing innovative medical solutions and comprehensive patient care services. With a strong emphasis on advanced health technologies, the company is strategically positioned in the telehealth and personalized medicine markets, supported by a robust research and development framework. As it navigates the rapidly evolving healthcare landscape, Akso Health Group presents an attractive investment opportunity for institutional investors seeking to capitalize on transformative trends within the industry.

Visit Website →

Cosmos Health Inc.

HEALTHCARE · MEDICAL DISTRIBUTION · USA

Cosmos Holdings Inc. is a vertically integrated pharmaceutical company. The company is headquartered in Chicago, Illinois.

Want to dig deeper into these stocks?